Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 369,968 shares of the medical equipment provider’s stock after purchasing an additional 37,063 shares during the quarter. Arrowstreet Capital Limited Partnership owned approximately 0.10% of Intuitive Surgical worth $193,108,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at $25,000. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical in the 4th quarter valued at about $26,000. BankPlus Trust Department acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at about $28,000. Kohmann Bosshard Financial Services LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter worth about $31,000. Finally, Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $36,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $491.84 on Monday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The stock has a market cap of $175.18 billion, a PE ratio of 76.73, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The stock’s 50-day moving average is $556.28 and its two-hundred day moving average is $532.97.

Insider Activity at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 8,900 shares of the company’s stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the sale, the executive vice president now directly owns 5,758 shares in the company, valued at approximately $2,793,033.06. This represents a 60.72 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 33,754 shares of company stock valued at $17,691,621. Insiders own 0.70% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on ISRG. Citigroup increased their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Erste Group Bank lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 17th. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Piper Sandler reiterated an “overweight” rating and set a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Finally, Robert W. Baird cut their price target on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a report on Tuesday, March 18th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.